Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Braz. arch. biol. technol ; 63: e20190196, 2020. tab, graf
Article in English | LILACS | ID: biblio-1132166

ABSTRACT

Abstract Endodontic infections result from oral pathogenic bacteria which reach and infect dental pulp, as well as surrounding tissues, through cracks, unrepaired caries and failed caries restorations. This study aims to determine the chemical composition of essential oil from Psidium cattleianum leaves (PC-EO) and to assess its antibacterial activity against endodontic bacteria. Antibacterial activity of PC-EO was evaluated in terms of its minimum inhibitory concentration (MIC) values by the broth microdilution method on 96-well microplates. Bacteria Porphyromonas gingivalis (MIC = 20 µg/mL), Prevotella nigrescens (MIC = 62.5 µg/mL), Fusobacterium nucleatum (MIC = 12.5 µg/mL), Actinomyces naeslundii (MIC = 50 µg/mL), Bacteroides fragilis (MIC = 12.5 µg/mL), Aggregatibacter actinomycetemcomitans (MIC = 6.25 µg/mL) and Peptostreptococcus anaerobius (MIC = 62.5 µg/mL) were evaluated and compared to chlorhexidine dihydrochloride (CDH), the positive control. PC-EO was obtained by hydrodistillation with the use of a Clevenger-type apparatus whereas its chemical composition was analyzed by gas chromatography-flame ionization detection (GC-FID) and gas chromatography-mass spectrometry (GC-MS). Viridiflorol (17.9%), β-caryophyllene (11.8%), 1,8-cineole (10.8%) and β-selinene (8.6%) were the major constituents found in PC-EO, which exhibited high antibacterial activity against all endodontic pathogens under investigation. Therefore, PC-EO, a promising source of bioactive compounds, may provide therapeutic solutions for the field of endodontics.


Subject(s)
Oils, Volatile/pharmacology , Chlorhexidine/pharmacology , Psidium/chemistry , Anti-Bacterial Agents/pharmacology , Peptostreptococcus/drug effects , Bacteroides fragilis/drug effects , Actinomyces/drug effects , Microbial Sensitivity Tests , Fusobacterium nucleatum/drug effects , Aggregatibacter actinomycetemcomitans/drug effects , Porphyromonas gingivalis/drug effects , Prevotella nigrescens/drug effects , Gas Chromatography-Mass Spectrometry
2.
Odovtos (En línea) ; 20(2): 71-79, May.-Aug. 2018. tab
Article in English | LILACS, BBO | ID: biblio-1091448

ABSTRACT

Abstract There are several controversies regarding the efficacy of homeopathic substances; however, these remedies are used in many countries for the treatment of various pathological conditions. The purpose of this study was to evaluate the in vitro antibacterial activity of two homeopathic tinctures Arsenicum album (mineral extract) and Lycopodium clavatum (plant extract) on the periodontal bacteria Actinomyces israelii, Streptococcus sanguinis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans and Phorphyromonas gingivalis (P. gingivalis). Materials and methods: Equal numbers of bacteria were seeded on agar plates containing enriched media with the homeopathic solutions at 1dH and 1cH dilutions. After 7 days of incubation under anaerobic conditions, colony forming units (CFUs) were counted. The antibacterial effect was calculated based on the total number of CFUs observed on non-tincture containing agar, and on the tincture containing plates. Results: No visible growth of any of the strains was observed on the plates containing Arsenicum album at any of the dilutions tested. In contrast, when Lycopodium clavatum at 1cH dilution was tested, only P. gingivalis was susceptible to this compound. Conclusions: The results suggest that the mineral extract tincture had a greater antibacterial activity than the plant extract tincture, also Lycopodium clavatum preparation could be an effective inhibitor of periodontal pathogens bacteria such as P. gingivalis.


Resumen Se necesita un mayor número de estudios in vitro e in vivo para validar estos resultados.


Subject(s)
Streptococcus sanguis/drug effects , Actinomyces/drug effects , Arsenicum Album/antagonists & inhibitors , Lycopodium clavatum/antagonists & inhibitors , Aggregatibacter actinomycetemcomitans/drug effects , Porphyromonas gingivalis/drug effects , Prevotella intermedia/drug effects , Plant Extracts/analysis , Pharmacodynamics of Homeopathic Remedy , Homeopathy
3.
J. appl. oral sci ; 26: e20170075, 2018. tab, graf
Article in English | LILACS, BBO | ID: biblio-893719

ABSTRACT

ABSTRACT Objective: The aim of this double-blind, placebo-controlled and parallel- arm randomized clinical trial was to evaluate the effects of Lactobacillus rhamnosus SP1-containing probiotic sachet and azithromycin tablets as an adjunct to nonsurgical therapy in clinical parameters and in presence and levels of Tannerella forsythia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. Material and Methods: Forty-seven systemically healthy volunteers with chronic periodontitis were recruited and monitored clinically and microbiologically at baseline for 3, 6 and 9 months after therapy. Subgingival plaque samples were collected from four periodontal sites with clinical attachment level ≥1 mm, probing pocket depth ≥4 mm and bleeding on probing, one site in each quadrant. Samples were cultivated and processed using the PCR technique. Patients received nonsurgical therapy including scaling and root planing (SRP) and were randomly assigned to a probiotic (n=16), antibiotic (n = 16) or placebo (n = 15) group. L. rhamnosus SP1 was taken once a day for 3 months. Azithromycin 500mg was taken once a day for 5 days. Results: All groups showed improvements in clinical and microbiological parameters at all time points evaluated. Probiotic and antibiotic groups showed greater reductions in cultivable microbiota compared with baseline. The placebo group showed greater reduction in number of subjects with P. gingivalis compared with baseline. However, there were no significant differences between groups. Conclusions: The adjunctive use of L. rhamnosus SP1 sachets and azithromycin during initial therapy resulted in similar clinical and microbiological improvements compared with the placebo group.


Subject(s)
Humans , Male , Female , Adult , Azithromycin/therapeutic use , Probiotics/therapeutic use , Lacticaseibacillus rhamnosus/chemistry , Chronic Periodontitis/drug therapy , Anti-Bacterial Agents/therapeutic use , Time Factors , Colony Count, Microbial , Placebo Effect , Periodontal Index , Polymerase Chain Reaction , Double-Blind Method , Analysis of Variance , Dental Scaling/methods , Treatment Outcome , Aggregatibacter actinomycetemcomitans/isolation & purification , Aggregatibacter actinomycetemcomitans/drug effects , Azithromycin/pharmacology , Porphyromonas gingivalis/isolation & purification , Porphyromonas gingivalis/drug effects , Statistics, Nonparametric , Probiotics/pharmacology , Dental Plaque/microbiology , Dental Plaque/drug therapy , Tannerella forsythia/isolation & purification , Tannerella forsythia/drug effects , Middle Aged , Anti-Bacterial Agents/pharmacology
4.
Braz. dent. j ; 22(5): 398-403, 2011. ilus, tab
Article in English | LILACS | ID: lil-601841

ABSTRACT

New periodontal disease treatments are needed to prevent infection progression. Photodynamic therapy (PDT) is one of the greatest pledges for this purpose. It involves the use of light of specific wavelength to activate a nontoxic photosensitizing agent in the presence of oxygen for eradication of target cells, and can be used for photokilling of microorganisms. This study evaluated in vitro the photodynamic effect of 0.01 percent toluidine blue-O (TBO) in combination with an AlGaInP diode laser light source on Aggregatibacter actinomycetemcomitans (A.a.) and Streptococcus sanguinis (S.s.). Suspensions (2 mL) containing A.a. and S.s. at 1.5 x 108 CFU/mL concentration were prepared and divided into 3 groups: Control group (no treatment), Dye group (inoculum and TBO for 5 min) and Dye/Laser group (inoculum, TBO for 5 min and laser for 3 min). Next, a dilution for subsequent subculture in 20 mL of Trypic Soy Agar (A.a) and Brucella Agar (S.s.) in Petri dishes (Pourplate Method) was done. Incubation of A.a. in microaerophilia and S.s. in aerobiosis at 35oC for 48 h was performed for subsequent visual counting of CFU/mL. Data were analyzed by one-way ANOVA and Tukey’s HSD test at 5 percent significance level. For both strains, the control group showed a significantly higher (p<0.05) bacterial growth (1.5 x 108 CFU/mL), while the Dye group presented no significant reduction (p>0.05) in the CFU counts. The Dye/Laser group presented a significant decrease in the CFU counts (p<0.05) compared with the Control group (61.53 percent for A.a. and 84.32 percent for S.s.). It may be concluded that PDT was effective in reducing the numbers of A.a. and S.s. in vitro.


Novos tratamentos são propostos para evitar a progressão da periodontite, sendo a terapia fotodinâmica (PDT) uma notória promessa. Sua aplicação associa o Azul de orto-toluidina a 0,01 por cento (TBO) e uma fonte luminosa a laser de diodo (TwinFlex, Mmoptics), liberando assim, toxinas às bactérias. O objetivo do estudo é avaliar in vitro a eficiência da PDT sobre Aggregatibacter actinomycetemcomitans (A.a.) e Streptococcus sanguinis (S.s.). Preparou-se suspensões distintas de 2 mL contendo A.a. e S.s. na concentração de 1,5x108 UFC/mL, e divisão de cada suspensão em 3 grupos: Controle (sem tratamento); Corante (suspensão e TBO por 5min) e Corante/Laser (suspensão, TBO por 5 min e laser por 3 min). Promoveu-se a diluição, a semeadura em 20 mL de TSA (A.a.) e de Ágar Brucella (S.s.), em placas de Petri (Método Pourplate), e a incubação da A.a. em microaerofilia e da S.s. em aerobiose, por 48 h a 35oC, para posterior contagem visual das UFC. Os grupos Controle mostraram ótimo crescimento bacteriano (1,5 x 108 UFC/mL). Os grupos Corante não apresentaram redução significativa para ambas bactérias. Os grupos Laser apresentaram redução em relação ao controle, 61,53 por cento para A.a. e 84,32 por cento para S.s. A análise estatística (ANOVA, p<0,05) corrobou que a PDT é eficaz na redução destas bactérias in vitro.


Subject(s)
Humans , Aggregatibacter actinomycetemcomitans/drug effects , Photochemotherapy/methods , Streptococcus sanguis/drug effects , Aggregatibacter actinomycetemcomitans/growth & development , Bacteriological Techniques , Bacterial Load/drug effects , Lasers, Semiconductor/therapeutic use , Microbial Viability/drug effects , Periodontal Diseases/drug therapy , Periodontal Diseases/microbiology , Photosensitizing Agents/therapeutic use , Streptococcus sanguis/growth & development , Time Factors , Tolonium Chloride/therapeutic use
5.
Article in English | IMSEAR | ID: sea-139878

ABSTRACT

Background: The development of periodontal disease has been thought to be associated with several restricted members of the oral anaerobic species, such as black-pigmented Porphyromonas species and Actinobacillus actinomycetemcomitans (Aa), in the subgingival environment. Apart from bacteria, certain viruses and fungi that are associated with periodontal disease are also present in the subgingival plaque . Materials and Methods: A randomized, double-blind, crossover split-mouth design was performed. A total of 16 patients suffering from generalized chronic periodontitis were selected for the study. The study period of 18 days was divided into two time-intervals, i.e. baseline (0 days) to 7 th day, with a washout period of 4 days followed by a second time interval of 7 days. The use of ozone and chlorhexidine gluconate (CHX) irrigation was randomized. Both the patient and the clinician evaluating the clinical parameters were blinded regarding the type of irrigation used. Results: The interpretation of clinical and microbial data is from baseline to 7 th day. A higher percentage of plaque index (12%), gingival index (29%) and bleeding index (26%) reduction was observed using ozone irrigation as compared to chlorhexidine. The percentile reduction of Aa (25%) using ozone was appreciable as compared to no change in Aa occurrence using chlorhexidine. By using O 3 and chlorhexidine, there was no antibacterial effect on Porphyromonas gingivalis (Pg) and Tannerella forsythensis. The antifungal effect of ozone from baseline (37%) to 7 th day (12.5%) was pronounced during the study period, unlike CHX, which did not demonstrate any antifungal effect. Conclusion: Ozone may be considered as an alternative management strategy due to its powerful ability to inactivate microorganisms. Also, there is growing evidence that ozone can be employed as a useful therapeutic agent in both dentistry and medicine.


Subject(s)
Aggregatibacter actinomycetemcomitans/drug effects , Aggressive Periodontitis/drug therapy , Anti-Infective Agents, Local/administration & dosage , Anti-Infective Agents, Local/therapeutic use , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Bacteroides/drug effects , Candida albicans/drug effects , Chlorhexidine/administration & dosage , Chlorhexidine/therapeutic use , Chronic Periodontitis/drug therapy , Cross-Over Studies , Cytomegalovirus/drug effects , Dental Plaque Index , Double-Blind Method , Gingival Hemorrhage/drug therapy , Herpesvirus 1, Human/drug effects , Herpesvirus 2, Human/drug effects , Herpesvirus 4, Human/drug effects , Humans , Oxidants, Photochemical/administration & dosage , Oxidants, Photochemical/therapeutic use , Ozone/administration & dosage , Ozone/therapeutic use , Periodontal Index , Porphyromonas gingivalis/drug effects , Therapeutic Irrigation , Time Factors , Time Factors
6.
Article in English | IMSEAR | ID: sea-51723

ABSTRACT

The present study was conducted to isolate aerobic as well as anaerobic microbes from patients of gingivitis and adult periodontitis and to study the susceptibility patterns of these isolates to different antibiotics. In our study all the samples belonging to the control as well as the study groups yielded microbes. Aerobes and facultative anaerobes were isolated from 100 percent and 96 percent cases of normal gingiva and orodental infections respectively. Anaerobes were isolated from 80 percent of the normal gingival samples and 97 percent of the cases of orodental infections. Metronidazole was found to be the best for the anaerobes while the aerobes and facultative anaerobes showed good susceptibility to cefazolin and cefotaxime.


Subject(s)
Aggregatibacter actinomycetemcomitans/drug effects , Adult , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Bacteria, Aerobic/drug effects , Bacteria, Anaerobic/drug effects , Cefazolin/pharmacology , Cefotaxime/pharmacology , Drug Resistance, Bacterial , Gingiva/microbiology , Gingivitis/microbiology , Humans , Metronidazole/pharmacology , Microbial Sensitivity Tests , Peptostreptococcus/drug effects , Periodontitis/microbiology , Staphylococcus/drug effects , Veillonella/drug effects
7.
DARU-Journal of Faculty of Pharmacy Tehran University of Medical Sciences. 2001; 9 (3-4): 37-9
in English | IMEMR | ID: emr-56606

ABSTRACT

Glycyrrhetinic acid is a major component of a traditional plant called Licorice. This substance has been found to have some pharmacological properties including anti-inflammatory, anti-viral, anti-bacterial, anti-fungal, anti-allergic, anti-carcinogenic and anti-peptic-ulcer. Glycyrrhetinic acid also affects against some parasites such as Trichomonas vaginalis. In this study, 55 hospital strains of Staphylococcus aureus and 32 Actinobacillus actinomycetemcomitans, were isolated from patient's specimens by culture method. Antibacterial activities of glycyrrhetinic acid against those microorganisms were investigated by determining minimum inhibitory concentration [MIC] and minimum bactericidal concentration [MBC] methods. The MIC for S. aureus and A. actinomycetemcomitans were 64 and 8 micro g/ml respectively. The MBC for S. aureus and A. actinomycetemcomitans were 64 and 16 micro g/ml respectively. It is concluded that Glycyrrhetinic acid is effective against Staphylococcus aureus and Actinobacillus actinomycetemcomitans in appropriate concentrations


Subject(s)
Staphylococcus aureus/drug effects , Aggregatibacter actinomycetemcomitans/drug effects
8.
Rev. Fac. Odontol. Bauru ; 6(1): 13-21, jan.-mar. 1998. tab
Article in Portuguese | LILACS, BBO | ID: lil-230045

ABSTRACT

Esta pesquisa se propôs avaliar a resposta clínica e microbiológica frente a um tratamento periodontal sequenciado em dois grupos de pacientes, um submetido à raspagem e outro à raspagem e antibiótico. Observou-se a resposta frente à raspagem (análise 1-0), os resultados da manutençäo com e sem antibiótico (análise 2-1) e a terapia mais efetiva em retardar a recidiva clínica e microbiológica (análise 3-2). Os dados obtidos permitiram concluir que com o estabelecimento de terapias de manutençäo com raspagem näo houve diferenças clínicas significantes entre os grupos com e sem antibiótico. O antibiótico foi incapaz de eliminar totalmente o actinobacillus actinomycetemcomitans, sendo mais eficiente na eliminaçäo dos microrganismos BANA positivos nas bolsas periodontais com o passar do tempo


Subject(s)
Humans , Male , Female , Adult , Adolescent , Aggressive Periodontitis/drug therapy , Aggressive Periodontitis/pathology , Periodontal Diseases/pathology , Periodontal Diseases/drug therapy , Aggregatibacter actinomycetemcomitans/drug effects , Aggressive Periodontitis/etiology , Anti-Bacterial Agents/pharmacology , Actinobacillus Infections/etiology , Actinobacillus Infections/pathology , Actinobacillus Infections/drug therapy , Actinobacillus Infections/transmission , Pathology, Oral , Dental Scaling/methods
9.
Indian J Pediatr ; 1996 Jul-Aug; 63(4): 569-70
Article in English | IMSEAR | ID: sea-83994

ABSTRACT

Actinobacillus actinomycetemcomitans, a gram-negative aerobic bacillus of the family Parvobacteriaceae which is a normal inhabitant of the oral flora, is a rare cause of human infection. We report a case of septic arthritis caused by this organism in an uncompromised child.


Subject(s)
Actinobacillus Infections/diagnosis , Aggregatibacter actinomycetemcomitans/drug effects , Arthritis, Infectious/diagnosis , Child, Preschool , Female , Humans , Knee/microbiology , Penicillins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL